Axsome Therapeutics, Inc. financial data

Symbol
AXSM on Nasdaq
Location
New York, NY
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 23 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 165% % -34%
Quick Ratio 6.5% % -19%
Debt-to-equity 800% % 74%
Return On Equity -254% % 12%
Return On Assets -28% % 45%
Operating Margin -26% % 64%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 51,153,289 shares 3.9%
Common Stock, Shares, Outstanding 50,882,766 shares 4.6%
Entity Public Float $4,400,000,000 USD 38%
Common Stock, Value, Issued $5,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 49,747,178 shares 3.8%
Weighted Average Number of Shares Outstanding, Diluted 49,747,178 shares 3.8%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $638,496,000 USD 66%
Research and Development Expense $183,279,000 USD -2%
Selling and Marketing Expense $440,402,000 USD 50%
General and Administrative Expense $63,273,000 USD 17%
Costs and Expenses $805,258,000 USD 21%
Operating Income (Loss) $166,762,000 USD 41%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $183,704,000 USD 36%
Income Tax Expense (Benefit) $530,000 USD -724%
Net Income (Loss) Attributable to Parent $183,174,000 USD 36%
Earnings Per Share, Basic -3.68 USD/shares 39%
Earnings Per Share, Diluted -3.68 USD/shares 39%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $322,933,000 USD 2.4%
Accounts Receivable, after Allowance for Credit Loss, Current $224,464,000 USD 58%
Inventory, Net $27,938,000 USD 78%
Assets, Current $588,986,000 USD 21%
Property, Plant and Equipment, Net $562,000 USD -3.8%
Operating Lease, Right-of-Use Asset $20,858,000 USD 287%
Intangible Assets, Net (Excluding Goodwill) $40,519,000 USD -14%
Goodwill $12,042,000 USD 0%
Assets $689,805,000 USD 21%
Accounts Payable, Current $65,537,000 USD -9%
Employee-related Liabilities, Current $36,938,000 USD 31%
Liabilities, Current $378,836,000 USD 65%
Operating Lease, Liability, Noncurrent $23,182,000 USD 283%
Liabilities $601,510,000 USD 18%
Retained Earnings (Accumulated Deficit) $1,305,961,000 USD -16%
Stockholders' Equity Attributable to Parent $88,295,000 USD 55%
Liabilities and Equity $689,805,000 USD 21%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $43,375,000 USD 19%
Net Cash Provided by (Used in) Financing Activities $29,270,000 USD
Net Cash Provided by (Used in) Investing Activities $338,000 USD -245%
Common Stock, Shares Authorized 150,000,000 shares 0%
Common Stock, Shares, Issued 50,882,766 shares 4.6%
Common Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $14,443,000 USD 74%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $322,933,000 USD 2.4%
Interest Paid, Excluding Capitalized Interest, Operating Activities $4,590,000 USD -6.4%
Deferred Tax Assets, Valuation Allowance $316,110,000 USD 12%
Deferred Tax Assets, Gross $323,246,000 USD 14%
Operating Lease, Liability $23,616,000 USD 200%
Depreciation $149,000 USD 13%
Payments to Acquire Property, Plant, and Equipment $338,000 USD 245%
Lessee, Operating Lease, Liability, to be Paid $29,227,000 USD 191%
Operating Lease, Liability, Current $434,000 USD -76%
Lessee, Operating Lease, Liability, to be Paid, Year Two $4,791,000 USD 90%
Lessee, Operating Lease, Liability, to be Paid, Year One $2,028,000 USD 13%
Operating Lease, Weighted Average Discount Rate, Percent 0.12 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $5,611,000 USD 160%
Lessee, Operating Lease, Liability, to be Paid, Year Three $4,807,000 USD 91%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits $3,267,000 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four $11,284,000 USD 252%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets $6,375,000 USD -0.27%
Deferred Tax Assets, Net of Valuation Allowance $34,000 USD
Share-based Payment Arrangement, Expense $93,752,000 USD 10%
Interest Expense $15,928,000 USD 26%
Preferred Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%